Rare diseases
Investigational molecules
Locations
Back to Lithuania174 clinical trials in Kaunas, Lithuania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LithuaniaKlinikiniai-Tyrimai.lt(opens in a new tab)Study on Risankizumab for Patients with Moderate to Severe Crohn's Disease
LithuaniaStudy Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer
LithuaniaStudy on UGN-102 (Mitomycin) for Treating Low Grade Non-Muscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence
LithuaniaStudy of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections
LithuaniaStudy on FX06 for Improving Acute Respiratory Distress Syndrome in Patients
LithuaniaStudy of Debio 4228 for Patients with Advanced or Metastatic Prostate Cancer
LithuaniaStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
LithuaniaStudy on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis
LithuaniaStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
LithuaniaStudy on the Safety and Effects of OMS906 for Patients with C3 Glomerulopathy and Idiopathic Immune Complex-Mediated Glomerulonephritis
LithuaniaStudy on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
LithuaniaStudy on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)
LithuaniaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on acute myeloid leukemia, various types of lung cancer, and bladder cancer treatments. Research includes innovative combination therapies and novel drug applications.
Emphasis on both early-stage and metastatic disease management.
Clinical investigations targeting systemic sclerosis, ulcerative colitis, and Crohn's disease. Studies evaluate new biological therapies and disease-modifying treatments.
Focus on improving quality of life and disease management.
Research into preventive healthcare including influenza vaccines and contraceptive methods. Studies examine both pediatric and adult populations.
Emphasis on safety and long-term effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
